Table 4. Adverse events reported by participants ( n  = 39) .

Adverse events	Mild	Moderate	Severe	Debilitating/Life threatening	Total
Anorexia	0	0	1	0	1 (2.9%)
Anxiety	0	1	0	0	1 (2.9%)
Constipation	1	0	0	0	1 (2.9%)
Fatigue	11	3	0	0	14 (40.0%)
Lethargy	0	1	0	0	1 (2.9%)
Nausea	0	0	1	0	1 (2.9%)
Seizure frequency increased	0	2	0	0	2 (5.7%)
Sepsis	0	0	0	1	1 (2.9%)
Somnolence	0	2	0	0	2 (5.7%)
Vomiting	0	1	0	0	1 (2.9%)
Weight loss	0	0	1	0	1 (2.9%)
Total	12 (34.2%)	10 (28.6%)	3 (8.6%)	1 (2.9%)	26 (74.3%)